Metformin Delays Satellite Cell Activation and Maintains Quiescence
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
The regeneration of the muscle tissue relies on the capacity of the satellite stem cell (SC) population to exit quiescence, divide asymmetrically, proliferate, and differentiate. In age-related muscle atrophy (sarcopenia) and several dystrophies, regeneration cannot compensate for the loss of muscle tissue. These disorders are associated with the depletion of the satellite cell pool or with the loss of satellite cell functionality. Recently, the establishment and maintenance of quiescence in satellite cells have been linked to their metabolic state. In this work, we aimed to modulate metabolism in order to preserve the satellite cell pool. We made use of metformin, a calorie restriction mimicking drug, to ask whether metformin has an effect on quiescence, proliferation, and differentiation of satellite cells. We report that satellite cells, when treated with metformin in vitro, ex vivo,or in vivo, delay activation, Pax7 downregulation, and terminal myogenic differentiation. We correlate the metformin-induced delay in satellite cell activation with the inhibition of the ribosome protein RPS6, one of the downstream effectors of the mTOR pathway. Moreover,in vivo administration of metformin induces a belated regeneration of cardiotoxin- (CTX-) damaged skeletal muscle. Interestingly, satellite cells treated with metformin immediately after isolation are smaller in size and exhibit reduced pyronin Y levels, which suggests that metformin-treated satellite cells are transcriptionally less active. Thus, our study suggests that metformin delays satellite cell activation and differentiation by favoring a quiescent, low metabolic state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin treatment is shown to delay satellite cell activation and maintain a quiescent, low metabolic state thereby maintaining stem cell numbers (Pavlidou et al. 2019).”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Pavlidou et al. 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: The Potential of Stem Cells in Adult Tissues Representative of the Three Germ Layers
Obokata, H., Kojima, K., Westerman, K. A., Yamato, M., Okano, T., Tsuneda, S., & Vacanti, C. A. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0385 · Cited by 25
RetractedRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
SATELLITE CELL OF SKELETAL MUSCLE FIBERS
Mauro, A. (1961) · The Journal of Cell Biology · doi:10.1083/jcb.9.2.493 · Cited by 3,683 · cited 1×
“In the adult muscle, under resting conditions, SCs are mitotically quiescent [2].”
BackgroundAerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057 · cited 1×
“On the other hand, stem cell activation, including satellite cell activation, is characterized by elevated energy demands and is mediated by an oxidative respiration to glycolytic metabolism shift [8, 9].”
BackgroundSatellite Cells and the Muscle Stem Cell Niche
Yin, H., Price, F., & Rudnicki, M. A. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2011 · Cited by 2,166 · cited 2×
“Newly formed myofibers can be readily distinguished in muscle cross sections for their small caliber and for the presence of centrally located myonuclei [1].”
BackgroundOWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 1×
“The main targets of metformin are hepatocyte mitochondria where it disrupts respiratory chain complex I leading to a decrease in the ATP/AMP ratio [19].”
BackgroundCellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720 · cited 1×
“Metformin (1,1-dimethylbiguanide hydrochloride) is a calorie restriction mimicking drug that is widely prescribed for the treatment of hyperglycemia in individuals with type II diabetes [18].”
BackgroundmTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676 · cited 1×
“These findings highlight a possible use of metformin as a pharmacological intervention for muscle stem cell maintenance during the repeated regeneration cycles in disease [49, 50] or in aging, when chronic activation of mTOR signaling occurs [51, 52].”
BackgroundAMP-activated protein kinase: an energy sensor that regulates all aspects of cell function
Hardie, D. G. (2011) · Genes & Development · doi:10.1101/gad.17420111 · Cited by 1,638 · cited 1×
“AMPK is a serine/threonine kinase which works as a sensor of changes in cellular energy levels and metabolic stress [21].”
BackgroundAutophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355 · cited 1×
“Other studies have focused on the pharmacological inhibition of p38 MAPK [46], silencing of the p16 cell cycle regulator [47], or augmentation of the autophagic flux [48] as different approaches for the rejuvenation of the geriatric muscle.”
BackgroundGeriatric muscle stem cells switch reversible quiescence into senescence
Sousa-Victor, P., Gutarra, S., García-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardí, M., Ballestar, E., González, S., Serrano, A. L., et al. (2014) · Nature · doi:10.1038/nature13013 · Cited by 1,010 · cited 1×
“Other studies have focused on the pharmacological inhibition of p38 MAPK [46], silencing of the p16 cell cycle regulator [47], or augmentation of the autophagic flux [48] as different approaches for the rejuvenation of the geriatric muscle.”
BackgroundCornelison, D. D. W., & Wold, B. J. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8721 · Cited by 935 · cited 1×
“Quiescent SCs express the transcription factor Pax7 [28].”
BackgroundDowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933 · cited 2×
“Specifically in MCF7 breast cancer cells, it has been shown that metformin inhibits cell growth through negative regulation of the mTOR pathway and 30% reduction in global protein synthesis [22].”
BackgroundThe aged niche disrupts muscle stem cell quiescence
Chakkalakal, J. V., Jones, K. M., Basson, M. A., & Brack, A. S. (2012) · Nature · doi:10.1038/nature11438 · Cited by 851
mTORC1 controls the adaptive transition of quiescent stem cells from G0 to GAlert
Rodgers, J. T., King, K. Y., Brett, J. O., Cromie, M. J., Charville, G. W., Maguire, K. K., Brunson, C., Mastey, N., Liu, L., Tsai, C.-R., et al. (2014) · Nature · doi:10.1038/nature13255 · Cited by 776 · cited 2×
“[11] which reports that mTOR activity is necessary and sufficient for the transition of SCs from a quiescent G0 phase into a quiescent, more stress responsive, GAlert phase.”
BackgroundRejuvenation of the muscle stem cell population restores strength to injured aged muscles
Cosgrove, B. D., Gilbert, P. M., Porpiglia, E., Mourkioti, F., Lee, S. P., Corbel, S. Y., Llewellyn, M. E., Delp, S. L., & Blau, H. M. (2014) · Nature Medicine · doi:10.1038/nm.3464 · Cited by 677 · cited 1×
“Other studies have focused on the pharmacological inhibition of p38 MAPK [46], silencing of the p16 cell cycle regulator [47], or augmentation of the autophagic flux [48] as different approaches for the rejuvenation of the geriatric muscle.”
BackgroundMetabolic Plasticity in Stem Cell Homeostasis and Differentiation
Folmes, C. D. L., Dzeja, P. P., Nelson, T. J., & Terzic, A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.002 · Cited by 669 · cited 1×
“Metabolic flexibility controls the balance between stem cell fates, as unique bioenergetic demands underlie quiescence, stem cell proliferation, and lineage specification [6].”
BackgroundNotch Signaling Is Necessary to Maintain Quiescence in Adult Muscle Stem Cells
Bjornson, C. R. R., Cheung, T. H., Liu, L., Tripathi, P. V., Steeper, K. M., & Rando, T. A. (2012) · Stem Cells · doi:10.1002/stem.773 · Cited by 598
Ryall, J. G., Dell’Orso, S., Derfoul, A., Juan, A., Zare, H., Feng, X., Clermont, D., Koulnis, M., Gutierrez-Cruz, G., Fulco, M., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2014.12.004 · Cited by 575
Mourikis, P., Sambasivan, R., Castel, D., Rocheteau, P., Bizzarro, V., & Tajbakhsh, S. (2012) · Stem Cells · doi:10.1002/stem.775 · Cited by 526 · cited 1×
“Maintenance of quiescence and the ability to regain quiescence after activation are essential for the long-term homeostasis of the stem cell pool [32, 33].”
BackgroundShort Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice
Sacco, A., Mourkioti, F., Tran, R., Choi, J., Llewellyn, M., Kraft, P., Shkreli, M., Delp, S., Pomerantz, J. H., Artandi, S. E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.11.039 · Cited by 512 · cited 1×
“These findings highlight a possible use of metformin as a pharmacological intervention for muscle stem cell maintenance during the repeated regeneration cycles in disease [49, 50] or in aging, when chronic activation of mTOR signaling occurs [51, 52].”
BackgroundSatellite cells, the engines of muscle repair
Wang, Y. X., & Rudnicki, M. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3265 · Cited by 491 · cited 2×
“One daughter cell returns to quiescence to reconstitute the stamina pool while the other one proliferates and differentiates to eventually form new myofibers [3].”
BackgroundShort-term calorie restriction enhances skeletal muscle stem cell function
Cerletti, M., Jang, Y. C., Finley, L. W. S., Haigis, M. C., & Wagers, A. J. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.002 · Cited by 371 · cited 3×
“[13] that AMPK activation by a low-calorie diet improves the activity of SCs in the muscles of old mice.”
BackgroundInfluentialSandri, M., Barberi, L., Bijlsma, A. Y., Blaauw, B., Dyar, K. A., Milan, G., Mammucari, C., Meskers, C. G. M., Pallafacchina, G., Paoli, A., et al. (2013) · Biogerontology · doi:10.1007/s10522-013-9432-9 · Cited by 340 · cited 1×
“[45] demonstrated an increased phosphorylation of RPS6 and activation of mTOR signaling in aged mice, in accord with the findings of Cerletti et al.”
ResultDefective myoblasts identified in Duchenne muscular dystrophy
Blau, H. M., Webster, C., & Pavlath, G. K. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4856 · Cited by 335
Webster, C., & Blau, H. M. (1990) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01233096 · Cited by 297 · cited 1×
“These findings highlight a possible use of metformin as a pharmacological intervention for muscle stem cell maintenance during the repeated regeneration cycles in disease [49, 50] or in aging, when chronic activation of mTOR signaling occurs [51, 52].”
BackgroundEvidence for a myogenic stem cell that is exhausted in dystrophic muscle
Heslop, L., Morgan, J. E., & Partridge, T. A. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.12.2299 · Cited by 297
Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation
Tang, A. H., & Rando, T. A. (2014) · The EMBO Journal · doi:10.15252/embj.201488278 · Cited by 294 · cited 12×
“On the other hand, Tang and Rando proposed that SC exit from quiescence necessitates an increase in autophagic flux which is mediated by Sirt1 [10].”
BackgroundInfluentialCellular and molecular mechanisms underlying muscular dystrophy
Rahimov, F., & Kunkel, L. M. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201212142 · Cited by 239
Staying alive: Metabolic adaptations to quiescence
Valcourt, J. R., Lemons, J. M. S., Haley, E. M., Kojima, M., Demuren, O. O., & Coller, H. A. (2012) · Cell Cycle · doi:10.4161/cc.19879 · Cited by 232
Lying low but ready for action: the quiescent muscle satellite cell
Montarras, D., L'honoré, A., & Buckingham, M. (2013) · The FEBS Journal · doi:10.1111/febs.12372 · Cited by 200 · cited 1×
“In addition, our results strengthen the notion that quiescent SCs have a low metabolic rate and support the view that their activation and entry into the cell cycle can be manipulated by interfering with their metabolism [43].”
ResultMitochondria as a Potential Regulator of Myogenesis
Wagatsuma, A., & Sakuma, K. (2013) · The Scientific World Journal · doi:10.1155/2013/593267 · Cited by 135 · cited 1×
“On the contrary, at day 8, the protein levels of Tom20 significantly increase in the metformin-treated samples, which is in accord with the belated differentiation of metformin-treated SCs since it is known that myogenic differentiation is followed by a switch to oxidative phosphorylation metabolism [29, 30].”
ResultMtor is necessary for proper satellite cell activity and skeletal muscle regeneration
Zhang, P., Liang, X., Shan, T., Jiang, Q., Deng, C., Zheng, R., & Kuang, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.032 · Cited by 133 · cited 1×
“Furthermore, SCs derived from mTOR-knockout mice exhibit defective proliferation and differentiation kinetics and express lower levels of Pax7, Myf5, MyoD, and myogenin [38].”
BackgroundBigot, A., Duddy, W. J., Ouandaogo, Z. G., Negroni, E., Mariot, V., Ghimbovschi, S., Harmon, B., Wielgosik, A., Loiseau, C., Devaney, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.067 · Cited by 125 · cited 1×
“Aged SCs fail to maintain quiescence, and once activated, commitment to the myogenic lineage is favored at the expense of self-renewal [34].”
BackgroundmTORC1 Activation during Repeated Regeneration Impairs Somatic Stem Cell Maintenance
Haller, S., Kapuria, S., Riley, R. R., O’Leary, M. N., Schreiber, K. H., Andersen, J. K., Melov, S., Que, J., Rando, T. A., Rock, J., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.008 · Cited by 111 · cited 2×
“have reported the transient activation of mTOR signaling in different cell types during tissue regeneration [39].”
BackgroundResultGordon, B. S., Delgado-Diaz, D. C., & Kostek, M. C. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.003 · Cited by 103 · cited 1×
“The natural phenol resveratrol is also reported to induce oxidative metabolism in mdx mice by increasing the levels and activity of SIRT1 [16] while favoring utrophin gene expression [17].”
BackgroundMetabolic remodeling agents show beneficial effects in the dystrophin- deficient mdx mouse model
Jahnke, V. E., van der Meulen, J. H., Johnston, H., Ghimbovschi, S. D., Partridge, T., Hoffman, E. P., & Nagaraju, K. (2012) · Skeletal Muscle · doi:10.1186/2044-5040-2-16 · Cited by 99 · cited 1×
“In accordance, chronic treatment with metabolic remodeling agents, such as AICAR and PPARδ agonist, favors oxidative metabolism in mdx mice [14, 15].”
BackgroundAberrant mTOR activation in senescence and aging: A mitochondrial stress response?
Nacarelli, T., Azar, A., & Sell, C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.11.004 · Cited by 94 · cited 1×
“These findings highlight a possible use of metformin as a pharmacological intervention for muscle stem cell maintenance during the repeated regeneration cycles in disease [49, 50] or in aging, when chronic activation of mTOR signaling occurs [51, 52].”
BackgroundLjubicic, V., Burt, M., Lunde, J. A., & Jasmin, B. J. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00357.2013 · Cited by 93 · cited 2×
“SIRT1, a nutrient sensor, regulates the autophagic flux in SC progeny, and loss of SIRT1 leads to a delay in SC activation [10].”
BackgroundSacco, F., Silvestri, A., Posca, D., Pirro, S., Gherardini, P. F., Castagnoli, L., Mann, M., & Cesareni, G. (2016) · Cell Systems · doi:10.1016/j.cels.2016.02.005 · Cited by 88 · cited 1×
“The molecular mechanism underlying this antiproliferative effect has been characterized by revealing the proteomic profile of metformin-treated MCF7 cells [23].”
BackgroundSelf-citationHafner, P., Bonati, U., Erne, B., Schmid, M., Rubino, D., Pohlman, U., Peters, T. T. A., Rutz, E., Frank, S., Neuhaus, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147634 · Cited by 85 · cited 1×
“Notably, metformin is now tested in clinical trials for the improvement of muscle function in patients with Duchenne muscular dystrophy [26, 27].”
BackgroundChronic AMPK stimulation attenuates adaptive signaling in dystrophic skeletal muscle
Ljubicic, V., Khogali, S., Renaud, J., & Jasmin, B. J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00183.2011 · Cited by 75 · cited 1×
“In accordance, chronic treatment with metabolic remodeling agents, such as AICAR and PPARδ agonist, favors oxidative metabolism in mdx mice [14, 15].”
BackgroundMetformin Protects Skeletal Muscle from Cardiotoxin Induced Degeneration
Langone, F., Cannata, S. M., Fuoco, C., Lettieri‐Barbato, D., Testa, S., Nardozza, A. P., Ciriolo, M. R., Castagnoli, L., Gargioli, C., & Cesareni, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114018 · Cited by 60 · cited 1×
“In skeletal muscles, metformin has been demonstrated to protect mouse muscles from cardiotoxin-induced damage [24] and ameliorate the PGC1A and utrophin expression in dystrophic mice [25].”
BackgroundSelf-citationLjubicic, V., & Jasmin, B. J. (2015) · Muscle & Nerve · doi:10.1002/mus.24692 · Cited by 59 · cited 1×
“In skeletal muscles, metformin has been demonstrated to protect mouse muscles from cardiotoxin-induced damage [24] and ameliorate the PGC1A and utrophin expression in dystrophic mice [25].”
BackgroundDifferential Staining of DNA and RNA
Darżynkiewicz, Z., Juan, G., & Srour, E. F. (2004) · Current Protocols in Cytometry · doi:10.1002/0471142956.cy0703s30 · Cited by 54 · cited 1×
“This staining protocol allows distinguishing quiescent cells (with low RNA levels) from activated cells in G1 which are characterized by higher RNA levels [31].”
BackgroundAdult muscle ‘stem’ cells can be sustained in culture as free-floating myospheres
Westerman, K. A., Penvose, A. R., Yang, Z., Allen, P. D., & Vacanti, C. A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.03.022 · Cited by 54 · cited 1×
“Ultralow attachment culture dishes allow formation of myospheres [41] from muscle-derived cells by providing a niche-like environment and by helping maintain a more primitive cell state [42].”
BackgroundMetabolic plasticity and hematopoietic stem cell biology
Hsu, P., & Qu, C.-K. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328360ab4d · Cited by 45 · cited 1×
“On the other hand, stem cell activation, including satellite cell activation, is characterized by elevated energy demands and is mediated by an oxidative respiration to glycolytic metabolism shift [8, 9].”
BackgroundHafner, P., Bonati, U., Rubino, D., Gocheva, V., Zumbrunn, T., Gueven, N., & Fischer, D. (2016) · Trials · doi:10.1186/s13063-016-1503-1 · Cited by 43 · cited 1×
“Notably, metformin is now tested in clinical trials for the improvement of muscle function in patients with Duchenne muscular dystrophy [26, 27].”
BackgroundRejuvenating stem cells to restore muscle regeneration in aging
Bengal, E., Perdiguero, E., Serrano, A. L., & Muñoz‐Cánoves, P. (2017) · F1000Research · doi:10.12688/f1000research.9846.1 · Cited by 34 · cited 1×
“Both intrinsic and extrinsic factors of the SC environment seem to be involved in aged SC loss of function, such as increased DNA damage, epigenetic modifications, or altered metabolic signaling [44].”
BackgroundLyons, C. N., Leary, S. C., & Moyes, C. D. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-040 · Cited by 33
Regulation of myoblast differentiation by metabolic perturbations induced by metformin
Pavlidou, T., Rosina, M., Fuoco, C., Gerini, G., Gargioli, C., Castagnoli, L., & Cesareni, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182475 · Cited by 33 · cited 4×
“The monitoring of SC cell growth was performed according to our previous report [12].”
BackgroundMethodInfluentialSelf-citationEvidence for Defective Myoblasts in Duchenne Muscular Dystrophy
Blau, H. M., Webster, C., Pavlath, G. K., & Chiu, C. (1985) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-4907-5_7 · Cited by 30
Cited by
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
“Metformin treatment is shown to delay satellite cell activation and maintain a quiescent, low metabolic state thereby maintaining stem cell numbers (Pavlidou et al. 2019).”
BackgroundControl of satellite cell function in muscle regeneration and its disruption in ageing
Sousa-Victor, P., García-Prat, L., & Muñoz-Cánoves, P. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00421-2 · Cited by 476
Giuliani, G., Rosina, M., & Reggio, A. (2021) · FEBS Journal · doi:10.1111/febs.16080 · Cited by 159
Self-citationEspino-González, E., Dalbram, E., Mounier, R., Gondin, J., Farup, J., Jessen, N., & Treebak, J. T. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.014 · Cited by 153
Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes
Hashimoto, Y., Takahashi, F., Okamura, T., Hamaguchi, M., & Fukui, M. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155585 · Cited by 132
Metadata
- Authors
- Pavlidou, T., Marinkovic, M., Rosina, M., Fuoco, C., Vumbaca, S., Gargioli, C., Castagnoli, L., & Cesareni, G.
- Affiliations
- University of Rome Tor Vergata (IT)
- Corresponding author
- Cesareni, Gianni
- ORCID
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2019-04-24
- Volume
- 2019
- Pages
- 1-19
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC6561664
- OpenAlex
- W2940725946
- Cited by
- 38
- References
- 52
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 13 · 2020: 9 · 2019: 1
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- H2020 European Research Council (322749)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- metformin, satellite cells, quiescence, muscle regeneration, sarcopenia, mTOR signaling, ribosomal protein S6, Pax7, myogenesis, skeletal muscle, cellular metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.